Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1957 1
1959 1
1960 1
1964 1
1965 5
1966 2
1967 4
1968 4
1969 1
1970 3
1971 3
1972 3
1973 1
1974 6
1975 12
1976 9
1977 14
1978 17
1979 18
1980 12
1981 18
1982 13
1983 28
1984 23
1985 32
1986 23
1987 38
1988 34
1989 30
1990 49
1991 38
1992 22
1993 49
1994 54
1995 38
1996 63
1997 52
1998 65
1999 75
2000 81
2001 70
2002 68
2003 95
2004 78
2005 94
2006 109
2007 109
2008 120
2009 88
2010 102
2011 121
2012 137
2013 163
2014 172
2015 173
2016 179
2017 182
2018 191
2019 174
2020 221
2021 199
2022 214
2023 215
2024 238
2025 292
2026 144

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,477 results

Results by year

Filters applied: . Clear all
Page 1
Anaplastic thyroid carcinoma.
Yang J, Barletta JA. Yang J, et al. Semin Diagn Pathol. 2020 Sep;37(5):248-256. doi: 10.1053/j.semdp.2020.06.005. Epub 2020 Jun 24. Semin Diagn Pathol. 2020. PMID: 32624319 Review.
Anaplastic thyroid carcinoma (ATC) is a rare but significant malignancy due to its high mortality rate. ...
Anaplastic thyroid carcinoma (ATC) is a rare but significant malignancy due to its high mortality rate. ...
CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment.
Pan Z, Xu T, Bao L, Hu X, Jin T, Chen J, Chen J, Qian Y, Lu X, Li L, Zheng G, Zhang Y, Zou X, Song F, Zheng C, Jiang L, Wang J, Tan Z, Huang P, Ge M. Pan Z, et al. Mol Cancer. 2022 Oct 3;21(1):190. doi: 10.1186/s12943-022-01658-x. Mol Cancer. 2022. PMID: 36192735 Free PMC article.
Anaplastic thyroid carcinoma (ATC) is an extremely malignant type of endocrine cancer frequently accompanied by extrathyroidal extension or metastasis through mechanisms that remain elusive. ...CREB3L1 knockdown dramatically attenuated invasion of ATC cells, …
Anaplastic thyroid carcinoma (ATC) is an extremely malignant type of endocrine cancer frequently accompanied by extrath …
The genomic and evolutionary landscapes of anaplastic thyroid carcinoma.
Zeng PYF, Prokopec SD, Lai SY, Pinto N, Chan-Seng-Yue MA, Clifton-Bligh R, Williams MD, Howlett CJ, Plantinga P, Cecchini MJ, Lam AK, Siddiqui I, Wang J, Sun RX, Watson JD, Korah R, Carling T, Agrawal N, Cipriani N, Ball D, Nelkin B, Rooper LM, Bishop JA, Garnis C, Berean K, Nicolson NG, Weinberger P, Henderson YC, Lalansingh CM, Tian M, Yamaguchi TN, Livingstone J, Salcedo A, Patel K, Vizeacoumar F, Datti A, Xi L, Nikiforov YE, Smallridge R, Copland JA, Marlow LA, Hyrcza MD, Delbridge L, Sidhu S, Sywak M, Robinson B, Fung K, Ghasemi F, Kwan K, MacNeil SD, Mendez A, Palma DA, Khan MI, Shaikh M, Ruicci KM, Wehrli B, Winquist E, Yoo J, Mymryk JS, Rocco JW, Wheeler D, Scherer S, Giordano TJ, Barrett JW, Faquin WC, Gill AJ, Clayman G, Boutros PC, Nichols AC. Zeng PYF, et al. Cell Rep. 2024 Mar 26;43(3):113826. doi: 10.1016/j.celrep.2024.113826. Epub 2024 Feb 26. Cell Rep. 2024. PMID: 38412093 Free PMC article.
Anaplastic thyroid carcinoma is arguably the most lethal human malignancy. It often co-occurs with differentiated thyroid cancers, yet the molecular origins of its aggressivity are unknown. We sequenced tumor DNA from 329 regions of thyroid canc …
Anaplastic thyroid carcinoma is arguably the most lethal human malignancy. It often co-occurs with differentiated th …
Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics.
Abe I, Lam AK. Abe I, et al. Curr Oncol Rep. 2021 Feb 13;23(3):31. doi: 10.1007/s11912-021-01019-9. Curr Oncol Rep. 2021. PMID: 33582932 Review.
PURPOSE OF REVIEW: Anaplastic thyroid carcinoma is a type of thyroid carcinoma with the most aggressive biological behaviour amongst thyroid cancer. ...Changes in expression of different microRNAs are also involved in the pathogenesis of …
PURPOSE OF REVIEW: Anaplastic thyroid carcinoma is a type of thyroid carcinoma with the most aggressive b …
Anaplastic thyroid carcinoma: Updates on WHO classification, clinicopathological features and staging.
Abe I, Lam AK. Abe I, et al. Histol Histopathol. 2021 Mar;36(3):239-248. doi: 10.14670/HH-18-277. Epub 2020 Nov 10. Histol Histopathol. 2021. PMID: 33170501 Review.
Anaplastic thyroid carcinoma is an uncommon carcinoma representing 1 to 4% of all thyroid cancers. ...The median survival of patients with anaplastic thyroid carcinoma reported was from 1 to 6 months. The terminology of the …
Anaplastic thyroid carcinoma is an uncommon carcinoma representing 1 to 4% of all thyroid cancers. ...The …
Dissecting Anaplastic Thyroid Carcinoma: A Comprehensive Clinical, Histologic, Immunophenotypic, and Molecular Study of 360 Cases.
Xu B, Fuchs T, Dogan S, Landa I, Katabi N, Fagin JA, Tuttle RM, Sherman E, Gill AJ, Ghossein R. Xu B, et al. Thyroid. 2020 Oct;30(10):1505-1517. doi: 10.1089/thy.2020.0086. Epub 2020 May 8. Thyroid. 2020. PMID: 32284020 Free PMC article.
Background: Anaplastic thyroid carcinoma (ATC) is nearly always fatal. Large studies on ATC are exceedingly rare. ...Results: The median patients' age was 68 years. Differentiated thyroid carcinoma (DTC) was present in 208 cases (58%), the most …
Background: Anaplastic thyroid carcinoma (ATC) is nearly always fatal. Large studies on ATC are exceedingly rare. ...Re …
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Haddad RI, Bischoff L, Ball D, Bernet V, Blomain E, Busaidy NL, Campbell M, Dickson P, Duh QY, Ehya H, Goldner WS, Guo T, Haymart M, Holt S, Hunt JP, Iagaru A, Kandeel F, Lamonica DM, Mandel S, Markovina S, McIver B, Raeburn CD, Rezaee R, Ridge JA, Roth MY, Scheri RP, Shah JP, Sipos JA, Sippel R, Sturgeon C, Wang TN, Wirth LJ, Wong RJ, Yeh M, Cassara CJ, Darlow S. Haddad RI, et al. J Natl Compr Canc Netw. 2022 Aug;20(8):925-951. doi: 10.6004/jnccn.2022.0040. J Natl Compr Canc Netw. 2022. PMID: 35948029
Anaplastic thyroid carcinoma is almost uniformly lethal, and iodine-131 imaging and radioactive iodine cannot be used. ...This article describes NCCN recommendations regarding management of medullary thyroid carcinoma and anaplastic th …
Anaplastic thyroid carcinoma is almost uniformly lethal, and iodine-131 imaging and radioactive iodine cannot be used. …
Anaplastic thyroid carcinoma: advances in molecular profiling and targeted therapy.
Jungels C, Pita JM, Costante G. Jungels C, et al. Curr Opin Oncol. 2023 Jan 1;35(1):1-9. doi: 10.1097/CCO.0000000000000918. Epub 2022 Nov 18. Curr Opin Oncol. 2023. PMID: 36398690 Review.
PURPOSE OF REVIEW: Anaplastic thyroid carcinomas (ATCs) are rare cancers with a globally very poor prognosis, because of their immensely aggressive behaviour, resulting in predominantly advanced stage of disease at diagnosis. ...
PURPOSE OF REVIEW: Anaplastic thyroid carcinomas (ATCs) are rare cancers with a globally very poor prognosis, because of their …
Immunotherapy for Anaplastic Thyroid Carcinoma.
Lim AM, Solomon BJ. Lim AM, et al. J Clin Oncol. 2020 Aug 10;38(23):2603-2604. doi: 10.1200/JCO.20.01437. Epub 2020 Jun 18. J Clin Oncol. 2020. PMID: 32552275 No abstract available.
Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAF(V600E)-Mutated Anaplastic Thyroid Carcinoma.
Hamidi S, Iyer PC, Dadu R, Gule-Monroe MK, Maniakas A, Zafereo ME, Wang JR, Busaidy NL, Cabanillas ME. Hamidi S, et al. Thyroid. 2024 Mar;34(3):336-346. doi: 10.1089/thy.2023.0573. Epub 2024 Feb 13. Thyroid. 2024. PMID: 38226606
Background: The dabrafenib plus trametinib combination (DT) has revolutionized the treatment of BRAF(V600E)-mutated anaplastic thyroid carcinoma (BRAFm-ATC). However, patients eventually develop resistance and progress. ...
Background: The dabrafenib plus trametinib combination (DT) has revolutionized the treatment of BRAF(V600E)-mutated anaplastic thy …
4,477 results